Status:
COMPLETED
Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent
Lead Sponsor:
Johnson and Johnson, S.A.
Conditions:
Coronary Arteriosclerosis
Eligibility:
All Genders
Brief Summary
The purpose of this study is: To evaluate the safety and performance of the Presillion stent in routine clinical practice.
Detailed Description
Primary endpoint: Composite of Major Adverse Cardiac Events (MACE), which includes cardiac death, myocardial infarction (Q-wave and non Q-wave) and clinically driven target lesion revascularization (T...
Eligibility Criteria
Inclusion
- All subjects treated with Presillion stent up to two de novo coronary artery lesions
Exclusion
- No specified
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT00968019
Start Date
April 1 2009
End Date
May 1 2011
Last Update
March 13 2013
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Garcia Da Orta
Almada, Portugal, 2805-951
2
Hospital de Santa Cruz
Lisbon, Portugal, 2799-523
3
Hospital Sao Joao
Porto, Portugal, 4200-319
4
Centro Hospitalar Vila Real
Vila Real, Portugal, 5000 - 508